1-154558459-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_017582.7(UBE2Q1):​c.95G>A​(p.Gly32Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,376,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

UBE2Q1
NM_017582.7 missense

Scores

3
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.22
Variant links:
Genes affected
UBE2Q1 (HGNC:15698): (ubiquitin conjugating enzyme E2 Q1) The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is 98% identical to the mouse counterpart. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055330247).
BS2
High AC in GnomAd4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
UBE2Q1NM_017582.7 linkuse as main transcriptc.95G>A p.Gly32Glu missense_variant 1/13 ENST00000292211.5 NP_060052.3
UBE2Q1XM_047424467.1 linkuse as main transcriptc.95G>A p.Gly32Glu missense_variant 1/12 XP_047280423.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
UBE2Q1ENST00000292211.5 linkuse as main transcriptc.95G>A p.Gly32Glu missense_variant 1/131 NM_017582.7 ENSP00000292211 P1Q7Z7E8-1
UBE2Q1ENST00000497453.1 linkuse as main transcriptn.122-94G>A intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000667
AC:
10
AN:
149816
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000595
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000197
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000128
AC:
5
AN:
39164
Hom.:
0
AF XY:
0.0000817
AC XY:
2
AN XY:
24478
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000794
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000105
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000627
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000106
AC:
13
AN:
1227024
Hom.:
0
Cov.:
30
AF XY:
0.0000116
AC XY:
7
AN XY:
602568
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000693
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000176
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.99e-7
Gnomad4 OTH exome
AF:
0.0000201
GnomAD4 genome
AF:
0.0000667
AC:
10
AN:
149926
Hom.:
0
Cov.:
31
AF XY:
0.0000819
AC XY:
6
AN XY:
73268
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000594
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000198
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000727
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 04, 2024The c.95G>A (p.G32E) alteration is located in exon 1 (coding exon 1) of the UBE2Q1 gene. This alteration results from a G to A substitution at nucleotide position 95, causing the glycine (G) at amino acid position 32 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
0.0072
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.020
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.50
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-0.20
N
REVEL
Benign
0.049
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0030
B
Vest4
0.32
MutPred
0.17
Gain of solvent accessibility (P = 0.024);
MVP
0.043
MPC
1.4
ClinPred
0.31
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549444803; hg19: chr1-154530935; API